New York, NY -- (SBWIRE) -- 06/22/2017 -- The analysts forecast the global peptide therapeutics market to grow at a CAGR of 7.92% during the period 2016-2020.

Peptides are organic compounds that are composed of amino acids linked chemically by peptide bonds. They are the most potent biologically active substances found in nature and are used to trigger, control, and maintain an individual's physiological processes. However, using peptides as therapeutic agents was always difficult as they are quite instable and cannot pass through cellular membranes. They also require a specific technology to tackle extensive and challenging steps in their synthesis. Over 80 peptides are marketed by companies that explore the probabilities of designing and engineering peptides that can overcome their natural limits. They can be introduced as a treatment for chronic indications.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/366377-global-peptide-therapeutics-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global peptide therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of prescription and generic drugs used to treat diseases.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Peptide Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Eli Lilly
- Novo Nordisk
- Sanofi
- Takeda Pharmaceutical
- Teva Pharmaceuticals

Other prominent vendors
- AbbVie
- Advanced Accelerator Applications
- Akashi Therapeutics
- Amgen
- Anthera Pharmaceuticals
- AstraZeneca
- Bachem
- Bristol-Myers Squibb
- Cardiorentis
- Corden Pharma International
- Debiopharm
- Derma Sciences
- GlaxoSmithKline
- Hanmi Pharmaceutical
- Insmed
- Ipsen
- Johnson & Johnson
- Lonza
- Mallinckrodt
- MolMed
- Merck
- Novartis
- Nymox Pharmaceutical
- Par Pharmaceuticals
- PeptiDream
- Polypeptide Group
- Radius Health
- Repligen
- Roche
- SciClone
- Shire
- The Medicines Company
- Transition Therapeutics
- X-Gen Pharmaceuticals
- Zealand Pharma
- Zydus Cadila

Market driver
- Increase in patient population
- For a full, detailed list, view our report

Market challenge
- High cost of therapy
- For a full, detailed list, view our report

Market trend
- Shifting focus toward untapped markets
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/366377-global-peptide-therapeutics-market-2016-2020

Table Of Contents – Major Key Points

PART 01: Executive summary
- Highlights

PART 02: Scope of the report
- Market overview
- Top-vendor offerings

PART 03: Market research methodology
- Research methodology
- Economic indicators

PART 04: Introduction
- Key market highlights

PART 05: Overview of peptides
- Peptide synthesis
- Optimization of peptides
- Stabilization of peptides

PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 07: Market segmentation based on route of administration
- Parenteral
- Oral
- Pulmonary
- Mucosal

PART 08: Market segmentation by drug class
- Somatostatins
- Vasopressin
- Calcitonins
- Luteinizing hormone (LH)-releasing hormone (LHRH)
- Glucagon and analogs
- Insulins
- Other

PART 09: Market segmentation by synthesis technology
- Liquid-phase peptide synthesis
- Solid-phase peptide synthesis
- Hybrid peptide synthesis

PART 10: Geographical segmentation
- Global peptide therapeutics market segmentation by geography 2015-2020
- Peptide therapeutics market in Americas
- Peptide therapeutics market in EMEA
- Peptide therapeutics market in APAC

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=366377

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.